Therefore, the expression of survivin, caspase-3, and caspase-7 could be used as genetic biomarkers for the evaluation of oocytes and embryos under an ART program in CCs of PCOS patients [36]. This evidence concerns the gene BIRC5 and polycystic ovary syndrome.